Basaria S. Male hypogonadism. Lancet. 2014;383(9924):1250–63. https://doi.org/10.1016/S0140-6736(13)61126-5.

Article  CAS  PubMed  Google Scholar 

Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–44. https://doi.org/10.1210/jc.2018-00229.

Article  PubMed  Google Scholar 

Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ, American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. Endocr Pract. 2002;8(6):440–56.

Article  PubMed  Google Scholar 

Spitzer M, Huang G, Basaria S, Travison TG, Bhasin S. Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol. 2013;9(7):414–24. https://doi.org/10.1038/nrendo.2013.73.

Article  CAS  PubMed  Google Scholar 

Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl. 2009;30(1):1–9. https://doi.org/10.2164/jandrol.108.006486.

Article  PubMed  Google Scholar 

Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93(7):2737–45. https://doi.org/10.1210/jc.2007-1972.

Article  CAS  PubMed  Google Scholar 

Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589–98. https://doi.org/10.1210/jcem.87.2.8201.

Article  CAS  PubMed  Google Scholar 

Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724–31. https://doi.org/10.1210/jcem.86.2.7219.

Article  CAS  PubMed  Google Scholar 

Morley JE, Kaiser FE, Perry HM 3rd, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46(4):410–3. https://doi.org/10.1016/s0026-0495(97)90057-3.

Article  CAS  PubMed  Google Scholar 

Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol. 1997;146(8):609–17. https://doi.org/10.1093/oxfordjournals.aje.a009326.

Article  CAS  PubMed  Google Scholar 

Travison TG, Vesper HW, Orwoll E, et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161–73. https://doi.org/10.1210/jc.2016-2935.

Article  PubMed  PubMed Central  Google Scholar 

Shigehara K, Izumi K, Kadono Y, Mizokami A. Testosterone and bone health in men: a narrative review. J Clin Med. 2021;10(3):530. https://doi.org/10.3390/jcm10030530. (Published 2021 Feb 2).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nassar GN, Leslie SW. Physiology, Testosterone. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

Bhasin S, Valderrábano RJ, Gagliano-Jucá T et al. Age-Related Changes in the Male Reproductive System. In: Feingold KR, Ahmed SF, Anawalt B, eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2022.

Kafel H, Braga-Basaria M, Basaria S. Opioid-induced androgen deficiency in men: prevalence, pathophysiology, and efficacy of testosterone therapy. Andrology. 2025. https://doi.org/10.1111/andr.70013.

Article  PubMed  Google Scholar 

Albright F. Osteoporosis. Ann Intern Med. 1947;27(6):861–82. https://doi.org/10.7326/AITC202401160.

Article  CAS  PubMed  Google Scholar 

Khosla S, Monroe DG. Regulation of bone metabolism by sex steroids. Cold Spring Harb Perspect Med. 2018;8(1):a031211. https://doi.org/10.1101/cshperspect.a031211. (Published 2018 Jan 2).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clarke BL, Khosla S. Androgens and bone. Steroids. 2009;74(3):296–305. https://doi.org/10.1016/j.steroids.2008.10.003.

Article  CAS  PubMed  Google Scholar 

Weber TJ. Battle of the sex steroids in the male skeleton: and the winner is.... J Clin Invest. 2016;126(3):829–32. https://doi.org/10.1172/JCI85006.

Article  PubMed  PubMed Central  Google Scholar 

Brown M. Skeletal muscle and bone: effect of sex steroids and aging. Adv Physiol Educ. 2008;32(2):120–6. https://doi.org/10.1152/advan.90111.2008.

Article  PubMed  Google Scholar 

Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23(3):279–302. https://doi.org/10.1210/edrv.23.3.0465.

Article  CAS  PubMed  Google Scholar 

Kalyanaraman H, Pal China S, Casteel DE, Pilz RB. Crosstalk between androgen receptor and protein kinase G signaling in bone: implications for osteoporosis therapy. Trends Pharmacol Sci. 2025;46(3):279–94. https://doi.org/10.1016/j.tips.2025.01.007.

Article  CAS  PubMed  Google Scholar 

Rojas-Zambrano JG, Rojas-Zambrano A, Rojas-Zambrano AF. Impact of testosterone on male health: a systematic review. Cureus. 2025;17(4):e82917. https://doi.org/10.7759/cureus.82917. (Published 2025 Apr 24).

Article  PubMed  PubMed Central  Google Scholar 

Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003;88(1):204–10. https://doi.org/10.1210/jc.2002-021036.

Article  CAS  PubMed  Google Scholar 

Michael H, Härkönen PL, Väänänen HK, Hentunen TA. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res. 2005;20(12):2224–32. https://doi.org/10.1359/JBMR.050803.

Article  CAS  PubMed  Google Scholar 

Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab. 1997;82(9):3128–35. https://doi.org/10.1210/jcem.82.9.4200.

Article  CAS  PubMed  Google Scholar 

Khosla S, Riggs BL. Androgens, estrogens, and bone turnover in men. J Clin Endocrinol Metab. 2003;88(5):2352–3. https://doi.org/10.1210/jc.2003-030054.

Article  CAS  PubMed  Google Scholar 

Sinnesael M, Boonen S, Claessens F, Gielen E, Vanderschueren D. Testosterone and the male skeleton: a dual mode of action. J Osteoporos. 2011;2011:240328. https://doi.org/10.4061/2011/240328.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grahnemo L, Marriott RJ, Murray K, et al. Associations of serum testosterone and SHBG with incident fractures in middle-aged to older men. J Clin Endocrinol Metab. 2025;110(7):1964–73. https://doi.org/10.1210/clinem/dgae703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng H, Zhang X, Li Y, et al. Age-related testosterone decline: mechanisms and intervention strategies. Reprod Biol Endocrinol. 2024;22(1):144. https://doi.org/10.1186/s12958-024-01316-5. (Published 2024 Nov 14).

Article  PubMed  PubMed Central